IRCT20190623043986N1尚未招募2 期
Evaluating the effectiveness of Lu177-dotatate in the treatment of recurrent meningioma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Pathologically-proved case of meningioma
- •Radiologic evidence of recurrence after at least two surgeries with no response to other standard therapies
- •Sufficient radiotracer uptake in the Tc99m-octreotide scan
- •Hemoglobulin (HB)>8 g/dl
- •White blood cell count (WBC) > 2500 /mm3
- •platelet count>70000 /mm3
- •Glomerular filtration rate (GFR) > 50ml/min
- •Consent to participate in the study
- •Life expectancy more than 6 months
排除标准
- •Pregnancy or lactation
- •Being candidate for other therapeutic measures
- •Development of unpredictable complications or other limiting or severe diseases
- •Severe hematologic complications
- •Severe renal complications
研究者
相似试验
招募中
2 期
A phase II trial of [177]Lutetium-DOTATATE in children with primary refractory or relapsed high-risk neuroblastomacancer of the nervous system10029211NeuroblastomaNL-OMON51935Karolinska University Hospital10
尚未招募
2 期
A study to evaluate the effectiveness of 177-Lu-DOTA Rituximab drug in adult patients diagnosed with the recurrence of low-grade B-cell lymphomas (a type of blood cancer).CTRI/2021/02/031578Tata Research Administrative Council TRAC
尚未招募
2 期
Effectiveness of Lu177-PSMA in treatment of refractory thyroid papillary cancer.IRCT20230803059015N1Shiraz University of Medical Sciences10
招募中
2 期
177Lu-DOTA-FAPI TherapyCondition 1: Brain tumors. Condition 2: Thyroid cancer resistant to radioactive iodine therapy. Condition 3: Gastrointestinal tumor. Condition 4: Lung cancer. Condition 5: Prostate cancer. Condition 6: Malignant female genital organs. Condition 7: Urinary tract cancer. Condition 8: Breast cancer. Condition 9: Malignant neoplasm of head, face and neck.Malignant neoplasm of brainMalignant neoplasm of thyroid glandMalignant neoplasms of digestive organsMalignant neoplasm of bronchus and lungMalignant neoplasm of prostateMalignant neoplasm of overlapping sites of female genital organsMalignant neoplasm of urinary organ, unspecifiedMalignant neoplasm of breastMalignant neoplasm of connective and soft tissue of head, face and neckC15-C26C57.8C68.9C49.0IRCT20210612051548N2Boushehr University of Medical Sciences30
进行中（未招募）
1 期
Trial investigating the activity of 177 Lutetium dotatate in children with cancer in their nervous systemEUCTR2012-000510-10-GBniversity of Birmingham24